Repeat-mediated Genetic and Epigenetic Changes at the FMR1 Locus in the Fragile X-related Disorders

Overview

Journal Front Genet

Date 2014 Aug 8

PMID 25101111

Citations 23

Authors

Karen Usdin

Bruce E Hayward

Daman Kumari

Rachel A Lokanga

Nicholas Sciascia

Xiao-Nan Zhao

Affiliations

Soon will be listed here.

Abstract

The Fragile X-related disorders are a group of genetic conditions that include the neurodegenerative disorder, Fragile X-associated tremor/ataxia syndrome (FXTAS), the fertility disorder, Fragile X-associated primary ovarian insufficiency (FXPOI) and the intellectual disability, Fragile X syndrome (FXS). The pathology in all these diseases is related to the number of CGG/CCG-repeats in the 5' UTR of the Fragile X mental retardation 1 (FMR1) gene. The repeats are prone to continuous expansion and the increase in repeat number has paradoxical effects on gene expression increasing transcription on mid-sized alleles and decreasing it on longer ones. In some cases the repeats can simultaneously both increase FMR1 mRNA production and decrease the levels of the FMR1 gene product, Fragile X mental retardation 1 protein (FMRP). Since FXTAS and FXPOI result from the deleterious consequences of the expression of elevated levels of FMR1 mRNA and FXS is caused by an FMRP deficiency, the clinical picture is turning out to be more complex than once appreciated. Added complications result from the fact that increasing repeat numbers make the alleles somatically unstable. Thus many individuals have a complex mixture of different sized alleles in different cells. Furthermore, it has become apparent that the eponymous fragile site, once thought to be no more than a useful diagnostic criterion, may have clinical consequences for females who inherit chromosomes that express this site. This review will cover what is currently known about the mechanisms responsible for repeat instability, for the repeat-mediated epigenetic changes that affect expression of the FMR1 gene, and for chromosome fragility. It will also touch on what current and future options are for ameliorating some of these effects.

Citing Articles

Longitudinal follow-up of metformin treatment in Fragile X Syndrome.

Seng P, Montanaro F, Biag H, Salcedo-Arellano M, Kim K, Ponzini M Front Psychol. 2024; 15:1305597.

PMID: 38939222 PMC: 11210589. DOI: 10.3389/fpsyg.2024.1305597.

Variation of FMRP Expression in Peripheral Blood Mononuclear Cells from Individuals with Fragile X Syndrome.

Randol J, Kim K, Ponzini M, Tassone F, Falcon A, Hagerman R Genes (Basel). 2024; 15(3).

PMID: 38540415 PMC: 10969917. DOI: 10.3390/genes15030356.

Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment.

Palumbo J, Thomas B, Budimirovic D, Siegel S, Tassone F, Hagerman R J Neurodev Disord. 2023; 15(1):1.

PMID: 36624400 PMC: 9830713. DOI: 10.1186/s11689-023-09475-z.

A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX).

Berry-Kravis E, Hagerman R, Budimirovic D, Erickson C, Heussler H, Tartaglia N J Neurodev Disord. 2022; 14(1):56.

PMID: 36434514 PMC: 9700889. DOI: 10.1186/s11689-022-09466-6.

Study of telomere length in men who carry a fragile X premutation or full mutation allele.

Albizua I, Chopra P, Allen E, He W, Amin A, Sherman S Hum Genet. 2020; 139(12):1531-1539.

PMID: 32533363 PMC: 8494119. DOI: 10.1007/s00439-020-02194-8.

References

Wohrle D, Salat U, Hameister H, Vogel W, Steinbach P . Demethylation, reactivation, and destabilization of human fragile X full-mutation alleles in mouse embryocarcinoma cells. Am J Hum Genet. 2001; 69(3):504-15. PMC: 1235481. DOI: 10.1086/322739. View

Taylor A, Tassone F, Dyer P, Hersch S, Harris J, Greenough W . Tissue heterogeneity of the FMR1 mutation in a high-functioning male with fragile X syndrome. Am J Med Genet. 1999; 84(3):233-9. View

Tassone F, Iwahashi C, Hagerman P . FMR1 RNA within the intranuclear inclusions of fragile X-associated tremor/ataxia syndrome (FXTAS). RNA Biol. 2006; 1(2):103-5. DOI: 10.4161/rna.1.2.1035. View

Sutherland G, Ashforth P . X-linked mental retardation with macro-orchidism and the fragile site at Xq 27 or 28. Hum Genet. 1979; 48(1):117-20. DOI: 10.1007/BF00273283. View

Powell W, Coulson R, Gonzales M, Crary F, Wong S, Adams S . R-loop formation at Snord116 mediates topotecan inhibition of Ube3a-antisense and allele-specific chromatin decondensation. Proc Natl Acad Sci U S A. 2013; 110(34):13938-43. PMC: 3752217. DOI: 10.1073/pnas.1305426110. View

Pastore L, Young S, Baker V, Karns L, Williams C, Silverman L . Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserve. Reprod Sci. 2012; 19(11):1226-31. PMC: 4051402. DOI: 10.1177/1933719112446074. View

Streuli I, Fraisse T, Ibecheole V, Moix I, Morris M, de Ziegler D . Intermediate and premutation FMR1 alleles in women with occult primary ovarian insufficiency. Fertil Steril. 2008; 92(2):464-70. DOI: 10.1016/j.fertnstert.2008.07.007. View

Braun K, Segal M . FMRP involvement in formation of synapses among cultured hippocampal neurons. Cereb Cortex. 2000; 10(10):1045-52. DOI: 10.1093/cercor/10.10.1045. View

Lia A, Seznec H, Hofmann-Radvanyi H, Radvanyi F, Duros C, Saquet C . Somatic instability of the CTG repeat in mice transgenic for the myotonic dystrophy region is age dependent but not correlated to the relative intertissue transcription levels and proliferative capacities. Hum Mol Genet. 1998; 7(8):1285-91. DOI: 10.1093/hmg/7.8.1285. View

10.

Lavedan C, Grabczyk E, Usdin K, Nussbaum R . Long uninterrupted CGG repeats within the first exon of the human FMR1 gene are not intrinsically unstable in transgenic mice. Genomics. 1998; 50(2):229-40. DOI: 10.1006/geno.1998.5299. View

11.

Murray A, Schoemaker M, Bennett C, Ennis S, MacPherson J, Jones M . Population-based estimates of the prevalence of FMR1 expansion mutations in women with early menopause and primary ovarian insufficiency. Genet Med. 2013; 16(1):19-24. PMC: 3914024. DOI: 10.1038/gim.2013.64. View

12.

Pretto D, Hunsaker M, Cunningham C, Greco C, Hagerman R, Noctor S . Intranuclear inclusions in a fragile X mosaic male. Transl Neurodegener. 2013; 2(1):10. PMC: 3668897. DOI: 10.1186/2047-9158-2-10. View

13.

Wang Y, Gellibolian R, Shimizu M, Wells R, Griffith J . Long CCG triplet repeat blocks exclude nucleosomes: a possible mechanism for the nature of fragile sites in chromosomes. J Mol Biol. 1996; 263(4):511-6. DOI: 10.1006/jmbi.1996.0593. View

14.

Grasso M, Faravelli F, Lo Nigro C, Chiurazzi P, Sperandeo M, Argusti A . Mosaicism for the full mutation and a microdeletion involving the CGG repeat and flanking sequences in the FMR1 gene in eight fragile X patients. Am J Med Genet. 1999; 85(3):311-6. DOI: 10.1002/(sici)1096-8628(19990730)85:3<311::aid-ajmg24>3.0.co;2-a. View

15.

van den Broek W, Nelen M, Wansink D, Coerwinkel M, Te Riele H, Groenen P . Somatic expansion behaviour of the (CTG)n repeat in myotonic dystrophy knock-in mice is differentially affected by Msh3 and Msh6 mismatch-repair proteins. Hum Mol Genet. 2002; 11(2):191-8. DOI: 10.1093/hmg/11.2.191. View

16.

Renciuk D, Zemanek M, Kejnovska I, Vorlickova M . Quadruplex-forming properties of FRAXA (CGG) repeats interrupted by (AGG) triplets. Biochimie. 2008; 91(3):416-22. DOI: 10.1016/j.biochi.2008.10.012. View

17.

Hahnen E, Eyupoglu I, Brichta L, Haastert K, Trankle C, Siebzehnrubl F . In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy. J Neurochem. 2006; 98(1):193-202. DOI: 10.1111/j.1471-4159.2006.03868.x. View

18.

Rousseau F, Heitz D, Biancalana V, Blumenfeld S, Kretz C, Boue J . Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med. 1991; 325(24):1673-81. DOI: 10.1056/NEJM199112123252401. View

19.

Halabi A, Ditch S, Wang J, Grabczyk E . DNA mismatch repair complex MutSβ promotes GAA·TTC repeat expansion in human cells. J Biol Chem. 2012; 287(35):29958-67. PMC: 3436174. DOI: 10.1074/jbc.M112.356758. View

20.

Shapiro L, Simensen R, Wilmot P, Fisch G, Vibert B, Fenwick R . Asymmetry of methylation with FMR-1 full mutation in two 45,X/46,XX mosaic females associated with normal intellect. Am J Med Genet. 1994; 51(4):507-8. DOI: 10.1002/ajmg.1320510443. View